NM_021098.3:c.5635G>A
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 1P and 4B. PP3BS2
The NM_021098.3(CACNA1H):c.5635G>A(p.Glu1879Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000212 in 1,558,020 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.5635G>A | p.Glu1879Lys | missense_variant | Exon 33 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.5650G>A | p.Glu1884Lys | missense_variant | Exon 32 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.5653G>A | p.Glu1885Lys | missense_variant | Exon 32 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.5617G>A | p.Glu1873Lys | missense_variant | Exon 32 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.5650G>A | p.Glu1884Lys | missense_variant | Exon 33 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.5635G>A | p.Glu1879Lys | missense_variant | Exon 33 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.5596G>A | p.Glu1866Lys | missense_variant | Exon 33 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.5617G>A | p.Glu1873Lys | missense_variant | Exon 32 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.5578G>A | p.Glu1860Lys | missense_variant | Exon 32 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.5635G>A | p.Glu1879Lys | missense_variant | Exon 33 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.5617G>A | p.Glu1873Lys | missense_variant | Exon 32 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.5635G>A | p.Glu1879Lys | missense_variant | Exon 33 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.5635G>A | p.Glu1879Lys | missense_variant | Exon 33 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.5635G>A | p.Glu1879Lys | missense_variant | Exon 33 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.5635G>A | non_coding_transcript_exon_variant | Exon 33 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.*1587G>A | non_coding_transcript_exon_variant | Exon 32 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.*716G>A | non_coding_transcript_exon_variant | Exon 33 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*3486G>A | non_coding_transcript_exon_variant | Exon 33 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*5079G>A | non_coding_transcript_exon_variant | Exon 31 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.*609G>A | non_coding_transcript_exon_variant | Exon 34 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.*494G>A | non_coding_transcript_exon_variant | Exon 33 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.*1247G>A | non_coding_transcript_exon_variant | Exon 34 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.*302G>A | non_coding_transcript_exon_variant | Exon 34 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.*302G>A | non_coding_transcript_exon_variant | Exon 34 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.5617G>A | non_coding_transcript_exon_variant | Exon 32 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.5635G>A | non_coding_transcript_exon_variant | Exon 33 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.5635G>A | non_coding_transcript_exon_variant | Exon 33 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.*751G>A | non_coding_transcript_exon_variant | Exon 33 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000637236.3 | n.*1587G>A | 3_prime_UTR_variant | Exon 32 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.*716G>A | 3_prime_UTR_variant | Exon 33 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*3486G>A | 3_prime_UTR_variant | Exon 33 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*5079G>A | 3_prime_UTR_variant | Exon 31 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.*609G>A | 3_prime_UTR_variant | Exon 34 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.*494G>A | 3_prime_UTR_variant | Exon 33 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.*1247G>A | 3_prime_UTR_variant | Exon 34 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.*302G>A | 3_prime_UTR_variant | Exon 34 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.*302G>A | 3_prime_UTR_variant | Exon 34 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711488.1 | n.*751G>A | 3_prime_UTR_variant | Exon 33 of 35 | ENSP00000518777.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152224Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000481 AC: 8AN: 166398 AF XY: 0.0000566 show subpopulations
GnomAD4 exome AF: 0.0000185 AC: 26AN: 1405678Hom.: 0 Cov.: 33 AF XY: 0.0000274 AC XY: 19AN XY: 694012 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000459 AC: 7AN: 152342Hom.: 0 Cov.: 34 AF XY: 0.0000537 AC XY: 4AN XY: 74494 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
- -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 1879 of the CACNA1H protein (p.Glu1879Lys). This variant is present in population databases (rs377103385, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with CACNA1H-related conditions. ClinVar contains an entry for this variant (Variation ID: 529614). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CACNA1H protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at